GEU2001849Y - Antiphlogistic Ointment - Google Patents

Antiphlogistic Ointment

Info

Publication number
GEU2001849Y
GEU2001849Y GEAU2001000946U GEU2001849Y GE U2001849 Y GEU2001849 Y GE U2001849Y GE AU2001000946 U GEAU2001000946 U GE AU2001000946U GE U2001849 Y GEU2001849 Y GE U2001849Y
Authority
GE
Georgia
Prior art keywords
antiphlogistic
antiphlogistic ointment
ointment
essence
auxiliary
Prior art date
Application number
Inventor
Elena Kereselidze-Giorgobiani
Iveri Maisuradze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to GEAU2001000946 priority Critical patent/GEU2001849Y/en
Publication of GEU2001849Y publication Critical patent/GEU2001849Y/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1. Technical Result Increase in pharmacological effect. 2. Essence An antiphlogistic ointment comprises alkaloid greater celandine extract (Chelidonium majus L) and an auxiliary. 3. Field of Application Medicine.
GEAU2001000946 2001-04-25 2001-04-25 Antiphlogistic Ointment GEU2001849Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GEAU2001000946 GEU2001849Y (en) 2001-04-25 2001-04-25 Antiphlogistic Ointment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAU2001000946 GEU2001849Y (en) 2001-04-25 2001-04-25 Antiphlogistic Ointment

Publications (1)

Publication Number Publication Date
GEU2001849Y true GEU2001849Y (en) 2001-10-10

Family

ID=45475995

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAU2001000946 GEU2001849Y (en) 2001-04-25 2001-04-25 Antiphlogistic Ointment

Country Status (1)

Country Link
GE (1) GEU2001849Y (en)

Similar Documents

Publication Publication Date Title
PL327146A1 (en) Antagonists of the gonadotrophin liberating hormone
MX9709915A (en) Peptidyl heterocycles useful in the treatment of thrombin related disorders.
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
AU4570699A (en) Nucleosidic and non-nucleosidic folate conjugates
EA200001043A2 (en) I:npy inhibitor for treating female sexual dysfunction
LU92381I2 (en) Macitentan and its pharmaceutically acceptable derivatives (OPSUMIT)
LU91624I2 (en) Canakinumab and its pharmaceutically acceptable derivatives (ILARIS®)
IL138144A0 (en) Precision alignment and assembly of microlenses and microcolumns
ATE294803T1 (en) PYRROLOBENZODIAZEPINES
DK1095656T3 (en) Pharmaceutical compositions with the cholinesterase inhibitor galanthamine
PL343018A1 (en) Glucocorticoid-selective anti-inflammatory agents
DE59700356D1 (en) Kombinationspräparat, enthaltend 5-methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid und n-(4-trifluormethylphenyl)-2-cyan-3-hydroxycrotonsäureamid
ATE248832T1 (en) ANTAGONISTS OF GONADOTROPIN-RELEASE HORMON
WO2002022145A3 (en) Components of canola for the treatment of cancer
AU2001215676A1 (en) Multiplication and in vitro flowering of rose cultivars
AU8154594A (en) Methods of inhibiting fertility in women
MX9805064A (en) Method for treating depression.
GEU2001849Y (en) Antiphlogistic Ointment
AU2001268547A1 (en) Mosfet and method for fabrication of mosfet with buried gate
MXPA02011558A (en) Novel mmp 2 mmp 9 inhibitors.
AU7736991A (en) Device and method for enhanced administration of physostigmine
WO2002022146A8 (en) Components of canola for treating hyperlipidemia
YU29803A (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
AU2001288519A1 (en) Substractive metallization structure and method of making
AU2001263786A1 (en) Purified proenzyme of dipeptidyl peptidase i (pro-dppi)